[Overview of the Ebola vaccines in pre-clinical and clinical development]. - Wikidata - wikimedia - TriplyDB

[Overview of the Ebola vaccines in pre-clinical and clinical development].

[Overview of the Ebola vaccines in pre-clinical and clinical development].

http://www.wikidata.org/entity/Q30245207

about

[Overview of the Ebola vaccines in pre-clinical and clinical development].

http://www.wikidata.org/entity/Q30245207

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@ast

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@en

type

label

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@ast

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@en

prefLabel

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@ast

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@en

P1433

Q30245207-4FC07902-A24B-4638-8833-C9D3C11E9678

P1476

Q30245207-EC87484B-B743-4E34-93DA-D1236923DCEE

P2093

Q30245207-E233AB1C-67E7-4FB8-894A-5B1BC4037A83

P2860

Q30245207-043D06C9-F78B-42A8-9565-14F7DFB42895

Q30245207-05D40CD2-DC8F-491D-B0DF-174A4686325D

Q30245207-11C1F8D9-8675-465D-B248-ED5350C258E9

Q30245207-1301C6BE-B0A4-49EB-9E38-E1572DB77386

Q30245207-2D8B3532-8AD6-493A-B966-869BE97F46A1

Q30245207-2EF2383A-F9C6-4FD9-AEBB-8A67F77A64EC

Q30245207-3BB17DA0-D948-4890-A8C4-87CCEEE6B8E9

Q30245207-3DF26C0C-7F68-4C0C-8765-83B3A8559143

Q30245207-4331513A-5026-4DC7-8A7D-EF1AEBDD087F

Q30245207-48C105FF-3B25-4283-A4D4-8EA111636C11

P2888

Q30245207-4AF425B2-8634-4C3B-969B-D3A728D822A7

P304

Q30245207-6D7B32D0-2832-462E-8BEF-E07C5D86C957

P31

Q30245207-E857A836-A7AE-4623-9E25-6293CF5224B5

P356

Q30245207-45C0D411-7B39-4267-9C6A-F294E6B37DE4

P407

Q30245207-8C33A91D-D618-4FCD-A079-C4629FFD384C

P433

Q30245207-BE8E8F34-B2D2-4206-AAA0-12FC0DBFC4B7

P478

Q30245207-330255C0-C56F-4E07-8183-C0CC568E1F8D

P50

Q30245207-DBCB2434-1D77-4852-B419-93E873A12057

P577

Q30245207-E20BC327-AB11-4B7A-A95F-8BAA9C7B1A8E

P6179

Q30245207-D961F2DA-3CA1-43DD-AD49-8523CC54C861

P698

Q30245207-031D2714-AE94-48F1-8C45-DF6DAE9D4FF8

P921

Q30245207-908E3293-8918-4092-94FB-84CF6186A070

Q30245207-C1E93055-6DDA-4B2A-A5D3-DF79EB9FAD12

P356

S13149-016-0521-2

P1433

Bulletin de la Société de pathologie exotique et de ses filiales

P1476

[Overview of the Ebola vaccines in pre-clinical and clinical development].

@en

P2093

P Buchy

http://www.w3.org/2001/XMLSchema#string

P2860

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Clinical development of Ebola vaccines

Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine

Development of a preventive vaccine for Ebola virus infection in primates

Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.

Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic.

On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.

A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

P2888

s13149-016-0521-2

P304

256-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13149-016-0521-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015736333

http://www.w3.org/2001/XMLSchema#string

P698

27646961

http://www.w3.org/2001/XMLSchema#string

P921

Vaccine against Ebola